Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

ProMIS Neurosciences Inc PMN

ProMIS Neurosciences Inc. is a clinical-stage biotechnology company. It is focused on generating and developing antibody therapeutics selectively targeting toxic misfolded proteins in neurodegenerative diseases such as Alzheimer’s disease (AD), amyotrophic lateral sclerosis (ALS) and multiple system atrophy (MSA). Its proprietary target discovery engine applies a thermodynamic, computational discovery platform-ProMIS and Collective Coordinates-to predict novel targets known as Disease Specific Epitopes on the molecular surface of misfolded proteins. Using this approach, the Company is developing novel antibody therapeutics for AD, ALS and MSA. Its product candidates are PMN310, PMN267, and PMN442. The PMN310 is a monoclonal antibody designed to treat AD by selectively targeting toxic, misfolded oligomers of amyloid-beta. PMN267 product candidate targeting ALS. PMN442 is a drug candidate being developed for MSA designed to selectively target and protect against pathogenic a-syn species.


NDAQ:PMN - Post by User

Comment by DavidKingCanadaon Jul 11, 2022 3:33pm
122 Views
Post# 34815988

RE:Only a complete idiot would sell right now

RE:Only a complete idiot would sell right now

You guys are so gullible that I actually feel bad for you.

There us no way a small unknown Canadian Company will ever be a Big Player in the Biopharm world.

There are many other MAINSTREAM Companies that will eat Promis alive without thinking twice.

The only thing Promis has is their Proprietary Software which can EASILY be Copied by a Indian Scammer which leaves Promis with Nada!

The SP will drop back down, there is no question about that. 

Promis also lied to us about a Covid19 Serology Test and JV with BCNI.

As soon as Promis as something viable it will be sold, not a JV.

You don't think the Companies that have been doing this for Decades also have the same exact skill set as Promis? They have BILLIONS of Dollars of funding. 

Promis cheated their long term Holders and the Boston Group own most of the 7 Million Shares.

Good riddance you guys are not worthy of Investing, stick to flipping Cheeseburgers at Wendys! 

<< Previous
Bullboard Posts
Next >>